NKILT Therapeutics is a new cell therapy biotech coming out of stealth mode, that is developing a novel approach of targeting NK cells to fight hard to treat leukemias and solid tumors. 
Our platform will be based on an allogeneic approach using armored NK cells, focused on a new undisclosed target. Our NK cells will not only directly kill cancer cells, but will also activate innate immunity and directly target the tumor’s defense mechanisms. 

NKILT Therapeutics

Org chart

Similar companies